ICD-10 Specific code J82: Pulmonary eosinophilia, not elsewhere classified

Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.

Translations

Language Translation
Flag for English language  English Pulmonary eosinophilia, not elsewhere classified
Flag for French language  French ร‰osinophilie pulmonaire, non classรฉe ailleurs

Hierarchical position

Level Code Title
1 X Diseases of the respiratory system
2 J80-J84 Other respiratory diseases principally affecting the interstitium
3 J82 Pulmonary eosinophilia, not elsewhere classified

Indicated medicines

Active Ingredient Description
Reslizumab

Reslizumab is a humanised monoclonal antibody (IgG4, ฮบ) against the human interleukin-5 (IL-5). Reslizumab binds specifically to IL-5 and interferes with IL-5 binding to its cell-surface receptor. IL-5 is a key cytokine responsible for the differentiation, maturation, recruitment and activation of human eosinophils. Reslizumab binds human IL-5 with picomolar affinity blocking its biological function; consequently survival and activity of eosinophils are reduced.